LEGN vs BIIB: Which Stock is Better?

Side-by-side comparison of Legend Biotech Corp and Biogen Inc in 2026

Comparison Updated:

LEGN

Legend Biotech Corp

$21.17

BIIB

Biogen Inc

$177.35

Key Metrics Comparison

MetricLEGNBIIBWinner
Market Cap$3.90B$26.03BBIIB
P/E RatioN/A20.04BIIB
EPS (TTM)$N/A$8.85BIIB
Revenue Growth0.6%-0.1%LEGN
Gross Margin20.0%78.9%BIIB

Analyze LEGN

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LEGN or BIIB a better investment?

Comparing LEGN and BIIB: Legend Biotech Corp has a market cap of $3.90B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LEGN and BIIB?

LEGN (Legend Biotech Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LEGN or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LEGN or BIIB?

LEGN has higher revenue growth at 0.6% vs -0.1% for BIIB.

Which company is more profitable: LEGN or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 20.0% for LEGN.

Which is the larger company: LEGN or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $3.90B for LEGN.

Should I buy LEGN or BIIB in 2026?

Both LEGN and BIIB have investment merit. LEGN trades at $21.17 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LEGN and BIIB stock?

Key differences: Market Cap ($3.90B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.6% vs -0.1%), Gross Margin (20.0% vs 78.9%).

Popular Stock Comparisons